Site Map Contact Us Search Back to Home
 
 
 
Pipeline Program


Recent news

Compugen Ltd. Reports Third Quarter 2014 Financial Results|29 October 2014
Compugen Discloses Successful Validation Results for Novel B7/CD28–like Cancer Immunotherapy Target Candidate |27 October 2014
Compugen Third Quarter 2014 Conference Call Scheduled for Wednesday, October 29, 2014 at 10:00 AM ET|22 October 2014
News on product candidates